PCIA
AMGN icon

Prime Capital Investment Advisors’s Amgen AMGN Stock Holding History

Prime Capital Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.17M Sell
17,523
-1,795
-9% -$640K 0.07% 198
2025
Q4 		$6.32M Buy
19,318
+3,711
+24% +$1.18M 0.08% 178
2025
Q3 		$4.4M Sell
15,607
-2,334
-13% -$677K 0.06% 220
2025
Q2 		$5.01M Sell
17,941
-8,567
-32% -$2.43M 0.07% 199
2025
Q1 		$8.26M Sell
26,508
-18,520
-41% -$5.47M 0.1% 157
2024
Q4 		$11.7M Sell
45,028
-3,393
-7% -$1.01M 0.17% 102
2024
Q3 		$15.6M Buy
48,421
+1,467
+3% +$480K 0.22% 81
2024
Q2 		$14.7M Sell
46,954
-7,084
-13% -$2.08M 0.22% 82
2024
Q1 		$15.4M Buy
54,038
+8,311
+18% +$2.43M 0.21% 92
2023
Q4 		$13.2M Buy
45,727
+6,885
+18% +$1.88M 0.2% 103
2023
Q3 		$10.4M Buy
38,842
+1,382
+4% +$345K 0.21% 93
2023
Q2 		$8.32M Sell
37,460
-3,128
-8% -$726K 0.16% 112
2023
Q1 		$9.81M Buy
40,588
+14,543
+56% +$3.57M 0.4% 57
2022
Q4 		$6.84M Buy
26,045
+24,083
+1,227% +$6.46M 0.26% 81
2022
Q3 		$442K Buy
1,962
+537
+38% +$130K 0.03% 256
2022
Q2 		$347K Buy
1,425
+230
+19% +$56.4K 0.02% 271
2022
Q1 		$269K Hold
1,195
– – 0.02% 306
2021
Q4 		$269K Buy
1,195
+148
+14% +$31.2K 0.01% 306
2021
Q3 		$223K Sell
1,047
-602
-37% -$139K 0.01% 278
2021
Q2 		$402K Buy
1,649
+823
+100% +$202K 0.02% 270
2021
Q1 		$206K Sell
826
-313
-27% -$74.7K 0.01% 241
2020
Q4 		$262K Buy
1,139
+343
+43% +$79.1K 0.02% 218
2020
Q3 		$202K Sell
796
-28
-3% -$6.94K 0.02% 240
2020
Q2 		$194K Sell
824
-389
-32% -$88.8K 0.02% 230
2020
Q1 		$246K Buy
1,213
+610
+101% +$133K 0.03% 186
2019
Q4 		$145K Buy
603
+3
+0.5% +$661 0.02% 215
2019
Q3 		$116K Buy
600
+474
+376% +$91K 0.02% 235
2019
Q2 		$23K Sell
126
-3
-2% -$537 ﹤0.01% 289
2019
Q1 		$25K Sell
129
-85
-40% -$16.2K 0.01% 224
2018
Q4 		$42K Buy
+214
New +$41.8K 0.02% 171

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Prime Capital Investment Advisors's AMGN Position: Q1 2026 in Review

Prime Capital Investment Advisors reduced its Amgen (AMGN) stake by 9.3% in Q1 2026, selling an estimated $640K and leaving 17,523 shares worth $6.17M. The position accounts for 0.07% of the portfolio, ranked #198.

Prime Capital Investment Advisors first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $15.6M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Prime Capital Investment Advisors held 17,523 shares of Amgen worth $6.17M as of Q1 2026.
  • Prime Capital Investment Advisors sold 1,795 Amgen shares in Q1 2026, an estimated $640K.
  • Amgen made up 0.07% of Prime Capital Investment Advisors's portfolio in Q1 2026, its #198 holding.
  • Prime Capital Investment Advisors first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Prime Capital Investment Advisors's Amgen position peaked at $15.6M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.